Latest Cultivation News

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

ECS Botanics is set to launch AVANI AVA, a new medicinal cannabis range specifically designed for women’s health, aiming to capture a growing market segment with targeted formulations.

Cann Group Limited has successfully restructured its debt, stabilizing its finances and boosting operational performance, while appointing Mike Ryan as its new Chairman to guide future growth.

PeopleIN Group reported a challenging FY25 with revenue down 6.5% and EBITDA down 10%, yet strengthened its balance sheet through debt reduction and a strategic sale. The company is poised to capitalise on Queensland's infrastructure boom and Defence sector opportunities.

OMG Group has secured its maiden purchase order for premium SANDAI matcha in Australia, marking a promising start to a new high-margin revenue channel ahead of FY26.

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

Lindian Resources has begun construction of the Tipume accommodation village at its Kangankunde Rare Earths Project in Malawi, marking a critical step towards operational readiness. The modern camp is designed to support up to 90 personnel and is expected to be completed by early 2026.

Cann Group Limited reminds eligible shareholders that its Share Purchase Plan (SPP) closes today, offering new shares at a discount plus free attaching options, pending shareholder approval.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

Cann Group Limited has secured a short-term extension on its National Australia Bank debt facilities and is finalising a $15.3 million settlement deed to release all associated securities.

Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.

Unith Ltd reports a 32% rise in Q1 FY26 cash receipts and unveils its breakthrough Streaming Avatars technology, alongside a successful $1.85 million capital raise.